Vascular � Endovascular � Angiography Core Lab

Le CRO spécialisé dans les dispositifs médicaux vasculaires avec accès à un core lab.

Une solide expertise dans les études cliniques vasculaires, avec accès à un centre de recherche vasculaire spécialisé et à un core lab d’angiographie, ainsi qu’à un site de recherche clinique ayant participé à plus de 30 essais cardiovasculaires. Des preuves cliniques EU MDR conçues selon les attentes des organismes notifiés.

Eclevar est un spécialiste CRO européen spécialisé dans les dispositifs médicaux, qui accompagne les promoteurs depuis les premières études chez l’humain jusqu’au CER et au PMCF dans le cadre du règlement européen MDR.

  • Spécialisation vasculaire et endovasculaireChirurgie endovasculaire et investigation clinique en interne
  • Accès à un core lab d’angiographieAngiographie, imagerie intravasculaire, échocardiographie, physiologie coronaire
  • Leadership clinique cardiovasculaireFormer T�V S�D lead cardiovascular reviewer
  • Preuves cliniques conformes au règlement EU MDRInvestigations cliniques, PMCF et évaluation clinique
  • Stents & stent-grafts
  • Catheters & guidewires
  • Prothèses endovasculaires
  • DSMB & CEC
  • Angiography core lab
Expertise vasculaire spécialisée

Une expertise spécialisée pour les études cliniques vasculaires.

Eclevar MedTech is positioned with access to a specialized vascular research site and angiography core laboratory, and a clinical research site actively participating in over 30 cardiovascular trials. Our specialist team works with in-house clinicians in endovascular surgery and clinical investigation.

Qu’est-ce qu’un dispositif médical vasculaire ?

Un dispositif médical vasculaire est utilisé lors d’une chirurgie ouverte ou de techniques endovasculaires afin de contrôler, diagnostiquer, surveiller ou traiter une maladie ou une lésion. It encompasses cardiovascular, peripheral vascular and neurovascular anatomy.

Une équipe vasculaire expérimentée

Our team specializes in implants, endovascular prosthesis and stents intended for use in arteries and veins, collaborating with in-house clinicians specialized in endovascular surgery and clinical investigation.

Reviewer examining angiography and vascular imaging data on screen for a clinical trial core lab
Dispositifs pris en charge

Exemples de produits que nous prenons en charge.

Interventionnel et administration endovasculaire

  • Cardiac ablation catheters
  • Intravascular imaging catheters
  • Balloon catheters & guidewires
  • Vascular closure devices

Implants, stents et greffons

  • Drug-eluting & bare metal stents
  • Stent-grafts (textile)
  • Vascular grafts (ePTFE)
  • Transcatheter & surgical valves

Aortique, neurovasculaire et dispositifs spécialisés

  • AAA treatment devices
  • Neurovascular flow diverters
  • Embolic & IVC filters
  • Renal artery denervation tools
Un seul partenaire, de la stratégie à la preuve clinique
  1. 01Stratégie clinique
  2. 02Faisabilité et centres
  3. 03Mise en place de l’étude
  4. 04Opérations cliniques et monitoring
  5. 05Données, imagerie et core lab
  6. 06DSMB & CEC
  7. 07Preuves cliniques
Cardiovascular leadership

Une équipe cardiovasculaire européenne reconnue

Portrait of Dr Mark Da Costa, Chief Operating Officer and Head of Cardiovascular at Eclevar MedTech

Dr Mark Da Costa

Directeur des opérations et responsable du pôle cardiovasculaire

Plus de 25 ans en chirurgie cardiaque et évaluation des dispositifs cardiovasculaires

  • Cardiac surgeon, and former T�V S�D lead cardiovascular reviewer
  • Reviewer experience across 400+ cardiovascular devices
  • Leads Eclevar's TAVI, structural heart and high-risk device programs

Pertinence pour un programme vasculaire : he has read cardiovascular clinical evidence from the Notified Body side, so gaps surface while the study can still address them.

Mark Da Costa on LinkedIn
Portrait of Sebastien Meier Piantanida, Chief Data Officer at Eclevar MedTech

S�bastien Meier Piantanida

Chief Data Officer � Biometrics & Data Systems

  • 30 years in clinical data management, EDC and biometrics
  • Expertise in CDISC, CDASH, SDTM and ADaM
  • Oversees validated data flows between sites, the core lab and statistics

Pertinence : core lab imaging and site data arrive as one analyzable data set.

S�bastien Meier Piantanida on LinkedIn
Portrait of Mathilde Renier, Senior Clinical Data Manager for cardiovascular studies at Eclevar MedTech

Mathilde Renier

Senior Clinical Data Manager � Cardiovascular

  • 10+ years in cardiovascular clinical data management
  • Coordinates imaging and endpoint data from the core lab to analysis
  • Supports VARC-3-aligned data collection, review and traceability

Pertinence : endpoint data is structured for review from the first database build.

Mathilde Renier on LinkedIn
Portrait of Charline Petitdemange, Lead Clinical Project Manager for cardiovascular programs at Eclevar MedTech

Charline Petitdemange

Lead Clinical Project Manager � Cardiovascular (France & UK)

  • 10+ years in clinical research and medical device studies
  • Leads cardiovascular investigations and PMCF studies from start-up to close-out
  • Manages site coordination, monitoring, timelines and cross-functional teams

Pertinence : one point of accountability for delivery across French and UK sites.

Charline Petitdemange on LinkedIn

Former positions are stated for biographical context only. Eclevar is independent and is not endorsed by the organizations named. Notified Body experience is professional background, not a medical qualification.

Supervision clinique

Services de DSMB et CEC.

Ensuring participant safety and data integrity through periodic risk-benefit evaluation and independent event adjudication.

Mise en place et gestion du DSMB

  • Charter & adjudication form development
  • Expert member selection
  • Participant dossier development
  • Meeting coordination & results communication

Comité des événements cliniques (CEC)

  • Identification of adjudicable events
  • Clinical document retrieval
  • Rigorous meeting minutes & documentation
  • Direct liaison with data management
Core Lab cardiovasculaire

Une imagerie reproductible pour des résultats fondés sur les preuves.

Cardiovascular medicine is increasingly dictated by evidence-based guidelines. Our Center for Advanced Imaging assesses the imaging component of trials to ensure it is reproducible and yields the best outcomes, in collaboration with the CORRIB core lab.

How imaging becomes clinical evidence in a vascular study

  1. 01Centres cliniquesTrained on the imaging protocol
  2. 02Acquisition des imagesOne standard across every site
  3. 03Analyse par le core labIndependent reading, blinded to the site
  4. 04Critères d’évaluation validésCEC adjudication, DSMB safety review
  5. 05Preuves cliniquesEndpoint data for evaluation and PMCF
The imaging chain in a vascular study, from acquisition at the site to the endpoint data used in the clinical evaluation. The figure describes a workflow and represents no study result.
  • Angiography core lab
  • Intravascular & echocardiography lab
  • Coronary physiology core lab
  • 4D echocardiography (LV size & EF)
Étude de cas

Patch vasculaire, classe III.

Patch vasculaire de classe III Vascular � Real world evidence Étude PMCF � Multicenter, Europe Étude PMCF

Intended safety and performance claims that existing evidence did not yet support.

Le défi en matière de preuves

Intended claims on safety and performance were not sufficiently supported by existing evidence. A comprehensive Étude PMCF was required under EU MDR Chapter VI and ISO 14155:2026.

Objectifs de l’étude

  • Confirm safety in carotid and femoral locations
  • Identify emergent risks based on factual evidence
  • Ensure continued acceptability of the benefit-risk ratio

Plan de l’étude

Multicenter real world evidence study. 250 to 300 subjects evaluated across 8 sites, with data retrieved from medical charts from baseline to 3 years post-surgery.

Rôle d’Eclevar

Eclevar designed the study, coordinated the participating sites and managed data collection, monitoring and reporting for the sponsor.

250 to 300subjects evaluated
8participating sites
3 yearspost-surgery data window
Class IIIdevice classification

Résultat en matière de preuves

  • Accepted by the Notified Body
  • Representative patient population
  • Validated long-term durability

A program-specific outcome, described with the sponsor's permission. It is specific to this device, indication and study population, and implies no regulatory outcome for any other program.

Vous planifiez une investigation clinique vasculaire ? Discuss the evidence strategy with our team before the protocol is fixed, when design choices still cost nothing to change.

Échangez avec nous sur votre stratégie de génération de preuves
Pourquoi Eclevar MedTech

Pourquoi choisir Eclevar comme partenaire.

01

Accès aux marchés internationaux

Support clinical trials in the EU, UK, Australia and Japan with one partner.

For you: one project team across regions, instead of separate vendors.

02

Intégration du Core Lab

Imaging endpoints read in collaboration with the CORRIB core lab.

For you: imaging and study data move through one evidence workflow.

03

Expertise produit

Clinical project managers specialized in complex vascular trials.

For you: vascular endpoints understood by the people running the study.

04

Équipe clinique interne

Dedicated registered nurses and technical specialists for research.

For you: site-facing work stays with Eclevar, not a subcontractor.

05

Expertise DSMB

A track record in Data Safety Monitoring Board management.

For you: independent safety oversight set up and run for you.

06

Technologie de nouvelle génération

Proprietary EDC, ePRO and e-consent technology designed to support vascular data capture.

For you: site, imaging and participant data in one connected environment.

Référentiels selon lesquels nous travaillons

  • EU MDR 2017/745
  • ISO 14155:2026
  • ISO 13485
  • 21 CFR Part 11
  • GDPR
Eclevar MedTech receiving the Platinum Award at the xShare and EUCROF Open Call Awards for Clinical Research in Amsterdam
Prix Platinum 2026

Eclevar MedTech and Milo took the Platinum Award at xShare & EUCROF.

Top prize in the xShare x European CRO Federation "EHDS & Clinical Research" Open Call, awarded to Eclevar MedTech and its Milo Health platform, presented at the EUCROF 2026 conference in Amsterdam. The award recognizes data innovation.

Co-funded by the European Union � Horizon Europe � Grant Agreement No. 101136734 � Amsterdam, 2 Feb 2026

Ils nous font confiance

La confiance des leaders du secteur vasculaire et cardiovasculaire.

Manufacturers choose Eclevar as their specialist CRO for vascular and endovascular programs. Read all client success stories.

Au sein du portefeuille élargi de clients Eclevar

Contenus officiels

Nos contenus, signés Eclevar.

Cover of the whitepaper written by Notified Body BSI and Eclevar on clinical evidence under the EU MDR
Whitepaper � BSI x Eclevar

A BSI and Eclevar whitepaper on the EU MDR.

Written with Notified Body BSI: a practical reading of the clinical evidence expectations under EU MDR 2017/745, relevant to any high risk device program, vascular and endovascular devices included.

Lire le livre blanc

Still from the RegenLab video testimonial on the PMCF program managed by Eclevar
Testimonial � RegenLab

A client's live testimonial on Eclevar's capability to run complex trials.

Eclevar manages RegenLab's PMCF program on chronic wound devices: a randomized study of 160 participants across 14 sites in 5 EU countries.

� Eclevar, with its tailor-made approach and advanced Milo Studio platform, represents a major strategic asset. �Antoine Turzi, CEO, RegenLab

Voir le témoignage

Radiology workstation used for medical device imaging evidence review under the EU MDR
Upcoming � T�V S�D x Eclevar

Breakthrough Device Technology under the EU MDR.

A Notified Body perspective on the designation, evidence generation and conformity assessment of breakthrough devices under the EU MDR. Joint publication to come, with Dr Nikhil Khadabadi, CMO, Eclevar MedTech.

Bientôt disponible

Questions

Les questions que les promoteurs vasculaires nous posent.

Qu’est-ce qu’un dispositif médical vasculaire ?

Un dispositif médical vasculaire est utilisé lors d’une chirurgie ouverte ou de techniques endovasculaires afin de contrôler, diagnostiquer, surveiller ou traiter une maladie ou une lésion. It spans cardiovascular, peripheral vascular and neurovascular anatomy, and includes stents, grafts, catheters, closure devices and implants for arteries and veins.

Why choose a specialist vascular device CRO in Europe?

Vascular programs under EU MDR need imaging core lab capability, endovascular clinical expertise, robust DSMB and CEC governance and Notified Body insight. Eclevar combines access to an angiography core lab with a clinical site active in over 30 cardiovascular trials and a former Notified Body reviewer on the leadership team.

What core lab capabilities does Eclevar offer for vascular trials?

Angiography core lab, intravascular and echocardiography lab, coronary physiology core lab and 4D echocardiography for left ventricular size and ejection fraction, delivered so the imaging component of a trial is reproducible and yields the best outcomes.

Does Eclevar provide DSMB and Clinical Events Committee services?

Yes. Eclevar sets up Data Safety Monitoring Boards (charter and adjudication forms, expert member selection, participant dossiers, meeting coordination) and Clinical Events Committees (event identification, clinical document retrieval, rigorous minutes and direct liaison with data management).

Which vascular devices does Eclevar cover?

Cardiac ablation and intravascular imaging catheters, AAA treatment devices, neurovascular flow diverters, drug-eluting and bare metal stents, embolic and IVC filters, balloon catheters and guidewires, transcatheter and surgical valves, vascular closure devices, ePTFE grafts and textile stent-grafts.

Can Eclevar run a PMCF or real world evidence study for a Class III vascular device?

Yes. Eclevar has delivered a multicenter real world evidence Étude PMCF for a Patch vasculaire de classe III, 250 to 300 subjects across 8 sites with data from baseline to 3 years post-surgery, under EU MDR Chapter VI and ISO 14155:2026.

Demande concernant un programme vasculaire

Prêt à faire avancer votre programme de dispositif vasculaire ?

Send the device description, the intended claims and the clinical evaluation gap. Our vascular team comes back with the evidence model that answers it and what it takes to run it.

Reforming Clinical Evaluation of Medical Devices in Europe